Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
10
2022
China Publishes Final GB Standard on E-Cigarettes: The Basis for Product Compliance Keller and Heckman LLP
May
10
2022
Calling All Whistleblowers: Department of Justice Launches Office of Environmental Justice Tycko & Zavareei LLP
May
9
2022
South Carolina’s Medical Marijuana Bill Ruled Unconstitutional, but Sponsor Vows to Keep Fighting
May
9
2022
Continuing Litigation of California’s Foie Gras Ban Keller and Heckman LLP
May
9
2022
Group Standards: An Often Overlooked Regulatory Pathway to Export Food to China Keller and Heckman LLP
May
6
2022
UK Government Publishes Guidance on The Implementation of The Food (Promotion and Placement) Regulations 2021 Squire Patton Boggs (US) LLP
May
5
2022
FDA Issues Delta-8 THC Warning Letters Keller and Heckman LLP
May
5
2022
Assessing the Playing Field After Mississippi’s Medical Cannabis Opt-Out Deadline Expires Bradley Arant Boult Cummings LLP
May
5
2022
FDA Authorizes NJOY ACE Tobacco-Flavored Electronic Nicotine Delivery System (ENDS) Products for Marketing Keller and Heckman LLP
May
4
2022
Final Medicare Advantage and Part D Rule will Likely Require Medicare Advantage Plans to Update 2023 Bids under Maximum Out-of-Pocket (MOOP) Policy Changes Mintz
May
4
2022
The Expanding Landscape of Alcohol Delivery Services McDermott Will & Emery
May
4
2022
Even Indirect Income from Cannabis Can Get You Banned From Bankruptcy Ward and Smith, P.A.
May
4
2022
Canada Publishes Dietary Guidelines Resource Keller and Heckman LLP
May
3
2022
Celebrity Collaborations Are All the Buzz: Six Key Considerations for Alcohol Beverage Brands and Celebrities ArentFox Schiff LLP
May
3
2022
Massachusetts for ARPA-H Mintz
May
3
2022
False Fruit Labeling Claim Moves Forward Keller and Heckman LLP
May
2
2022
Attorney General Garland Reconfirms the DOJ’s Hands-Off Approach Toward Federal Marijuana Prosecution
May
2
2022
OIG Says that Increasing Use of Biosimilars Could Reduce Part D Spending Mintz
May
2
2022
Litigation Minute: Defending Consumer Class Action Claims Involving PFAS K&L Gates
May
2
2022
New Draft Guidance on FDA’s Accredited Third-Party Certification Program Keller and Heckman LLP
May
1
2022
Northern District of Illinois Decisions Find Access or Disclosure Exclusion Precludes Coverage for BIPA Claims, Creating a New Split in the District Wilson Elser Moskowitz Edelman & Dicker LLP
Apr
29
2022
FDA Issues Draft Action Levels for Lead in Juice Keller and Heckman LLP
Apr
29
2022
International Cooperation under China’s Proposed Implementing Rules for Human Genetic Resources Management Sheppard, Mullin, Richter & Hampton LLP
Apr
29
2022
How Pharmacies Can Defend Against PBM Audits Oberheiden P.C.
Apr
29
2022
New Guidance for Management of Biological Foodborne Outbreaks, and Identification of CCPs Keller and Heckman LLP
Apr
28
2022
FDA Updates FSVP Guidance on UFI Keller and Heckman LLP
Apr
28
2022
India: Another Booming Market for Alternative Proteins in Asia Keller and Heckman LLP
Apr
28
2022
The Metaverse: Alcohol Beverage Industry’s Next Marketing Frontier? ArentFox Schiff LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins